https://wikimd.org/index.php?action=history&feed=atom&title=F-11%2C461F-11,461 - Revision history2026-04-25T23:11:11ZRevision history for this page on the wikiMediaWiki 1.44.2https://wikimd.org/index.php?title=F-11,461&diff=5805298&oldid=prevPrab: CSV import2024-05-20T06:44:24Z<p>CSV import</p>
<p><b>New page</b></p><div>[[File:F-11,461.svg|thumb|right]] '''F-11,461''' is a chemical compound that has been studied for its potential pharmacological properties. It is classified as a [[serotonin receptor]] agonist, specifically targeting the [[5-HT1A receptor]].<br />
<br />
==Chemical Structure and Properties==<br />
F-11,461 is a synthetic compound with a complex molecular structure. The exact chemical formula and molecular weight of F-11,461 are essential for understanding its pharmacokinetics and pharmacodynamics. The compound's structure allows it to interact with specific [[neurotransmitter]] receptors in the brain, influencing various physiological and psychological processes.<br />
<br />
==Pharmacology==<br />
F-11,461 primarily acts as an agonist at the [[5-HT1A receptor]], a subtype of the [[serotonin receptor]]. This receptor is involved in the regulation of mood, anxiety, and other cognitive functions. By binding to the 5-HT1A receptor, F-11,461 can modulate the release of [[serotonin]], a key neurotransmitter in the [[central nervous system]].<br />
<br />
===Mechanism of Action===<br />
The mechanism of action of F-11,461 involves its interaction with the 5-HT1A receptor, leading to changes in [[neurotransmitter]] release and neuronal activity. This interaction can result in various therapeutic effects, including anxiolytic and antidepressant properties. The compound's efficacy and potency are determined by its binding affinity and intrinsic activity at the receptor site.<br />
<br />
==Potential Therapeutic Uses==<br />
Due to its action on the 5-HT1A receptor, F-11,461 has been investigated for its potential use in treating conditions such as [[anxiety disorders]], [[depression]], and other mood-related disorders. Research is ongoing to determine its safety, efficacy, and potential side effects in clinical settings.<br />
<br />
==Research and Development==<br />
F-11,461 is still under investigation, with numerous studies focusing on its pharmacological profile and therapeutic potential. Preclinical and clinical trials are essential to establish its safety and effectiveness for human use. The compound's development involves collaboration between [[pharmaceutical companies]], [[research institutions]], and regulatory agencies.<br />
<br />
==See Also==<br />
* [[Serotonin]]<br />
* [[5-HT1A receptor]]<br />
* [[Anxiety disorder]]<br />
* [[Depression (mood)]]<br />
* [[Neurotransmitter]]<br />
<br />
==References==<br />
{{Reflist}}<br />
<br />
==External Links==<br />
{{No external links}}<br />
<br />
[[Category:Serotonin receptor agonists]]<br />
[[Category:Experimental drugs]]<br />
[[Category:Pharmacology]]<br />
[[Category:Neurotransmitters]]<br />
<br />
{{medicine-stub}}</div>Prab